Abstract
It is acknowledged that there are a myriad of acute and chronic co-morbidities associated with psychosexual concerns [1]. As radical prostatectomy is one of the most widely accepted treatments for prostate cancer [2], there are “to be expected” side effects (EAU Guidelines 2016). There are conflicting rates of erectile dysfunction, which may not only be associated with degree of surgery, but also presence of co-morbidities [3]. Vascular, cardiac and diabetic comorbidities have the greatest impact [2, 4]. Age will not improve erectile function [5]. Additionally, if a patient has poor erections before surgery, post operatively, erections will not improve [6]. This is also a taboo area, which may act as a barrier to psychosexual care.
You have full access to this open access chapter, Download chapter PDF
It is acknowledged that there are a myriad of acute and chronic co-morbidities associated with psychosexual concerns [1]. As radical prostatectomy is one of the most widely accepted treatments for prostate cancer [2], there are “to be expected” side effects (EAU Guidelines 2016). There are conflicting rates of erectile dysfunction, which may not only be associated with degree of surgery, but also presence of co-morbidities [3]. Vascular, cardiac and diabetic comorbidities have the greatest impact [2, 4]. Age will not improve erectile function [5]. Additionally, if a patient has poor erections before surgery, post operatively, erections will not improve [6]. This is also a taboo area, which may act as a barrier to psychosexual care.
References
Kendirci M, Bejma J, Hellstrom WJG. Update on erectile dysfunction in prostate cancer patients. Curr Opin Urol. 2006;16:186–95.
Teloken PE, Mulhall JP. Erectile function following prostate cancer treatment: factors predicting recovery. Sexual Medicine Reviews. 2013;1:91–103.
Sherer BA, Levine LA. Current management of erectile dysfunction in prostate cancer survivors. Curr Opin Urol. 2014;24:401–6.
Miner MM. Erectile dysfunction: a harbinger for cardiovascular events and other comorbidities, thereby allowing a ‘window of curability’. Int J Clin Pract. 2009;63:1123–6.
Albersen M, Orabi H, Lue TF. Evaluation and treatment of erectile dysfunction in the aging male: a mini-review. Gerontology. 2012;58:3–14.
Han M, Trock BJ, Partin AW, Humphreys EB, Bivalacqua TJ, Guzzo TJ, Walsh PC. The impact of preoperative erectile dysfunction on survival after radical prostatectomy. BJU Int. 2010;106:1612–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Goonewardene, S.S., Persad, R. (2018). Impact of Acute and Chronic Co-morbidities on Psychosexual Concerns. In: Prostate Cancer Survivorship . Springer, Cham. https://doi.org/10.1007/978-3-319-65358-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-65358-7_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65357-0
Online ISBN: 978-3-319-65358-7
eBook Packages: MedicineMedicine (R0)